The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NOGA: Neoadjuvant treatment optimization via MRI-guided de-escalation in stage II–III TNBC—A phase 2 study.
 
Tal Sella
Honoraria - AstraZeneca; Gilead Sciences; Lilly; MSD; Novartis; Roche; Stemline Therapeutics
Consulting or Advisory Role - Novartis; Pfizer; Roche
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - Pfizer; Roche; Stemline Therapeutics
 
Amir Sonnenblick
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Progenetics; Rhenium/Oncotest; Roche; Stemline Therapeutics
Speakers' Bureau - Gilead Sciences; Lilly; Novartis; Pfizer; Roche
Research Funding - Gilead Sciences; Novartis; Roche
Travel, Accommodations, Expenses - Celgene; Medison; MSD; NeoPharm; Pfizer; Roche
 
Miri Sklair Levy
No Relationships to Disclose
 
Orit Golan
No Relationships to Disclose
 
Nora Balint-Lahat
No Relationships to Disclose
 
Asia Zubkov
No Relationships to Disclose
 
Einav Gal-Yam
Honoraria - AstraZeneca; Lilly; msd; Pfizer; Roche; Sermonix Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; MSD Oncology; Novartis; roche
Travel, Accommodations, Expenses - Gilead Sciences (Inst); msd; Pfizer (Inst); Roche
 
Yael Bar
Consulting or Advisory Role - Lilly; Novartis; Novartis; Pfizer; Stemline Therapeutics
Speakers' Bureau - AstraZeneca; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche; Stemline Therapeutics
Travel, Accommodations, Expenses - AstraZeneca; Roche